Paul Thomen

Tuesday, 18 June 2013

Global Bioinformatics Market Excepted to Reach CAGR of 20.9 percent by 2017

Bioinformatics is a scientific discipline that deals with the retrieval, storage, processing, analysis, and management of biological information through computational techniques. It uses mathematics, biology, and information technology to understand the biological importance of an extensive variety of data. Bioinformatics technologies are used in various pharmaceutical and biotechnology sectors. It is majorly used in the medical sector, driven by the increasing use of bioinformatics for the drug discovery and development process.

The global bioinformatics market was valued at $2.9 billion in 2012 and is poised to reach $7.5 billion by 2017 at a CAGR of 20.9%. The growth of the bioinformatics market is driven by decrease in cost of DNA sequencing, increasing government initiatives and funding, and growing use of bioinformatics in drug discovery and biomarkers development processes. It is expected that the market will offer opportunities for bioinformatics solutions manufacturers with the introduction and adoption of upcoming technologies such as nanopore sequencing and cloud computing. However, factors such as dearth of skilled personnel to ensure proper use of bioinformatics tools and lack of integration of a wide variety of data generated through various bioinformatics platforms are hindering the growth of the market. Manufacturers of bioinformatics solutions will face further challenges with regard to industry consolidation and management of high volume data.

North America accounted for the largest market share of the bioinformatics market, followed by Europe, in 2012. However, Asian and Latin American countries represent emerging markets, owing to a rise in research outsourcing by pharmaceutical giants, increasing number of Contract Research Organizations (CROs), rise in public and private sector investment, and growing industry -academia partnerships. The major players in the bioinformatics market are Accelrys, Inc. (U.S.), Affymetrix, Inc. (U.S.), Life Technologies Corporation (U.S.), Illumina, Inc. (U.S.), and CLC bio. (Denmark).

Scope of the Report

This research report categorizes and analyzes the global bioinformatics market on the basis of sectors, product and services, and applications. These markets are further divided into segments and sub-segments, to provide exhaustive value market analysis for the years 2010, 2011, 2012, and forecast to 2017. Each market is comprehensively analyzed at a granular level by geography (North America, Europe, Asia-Pacific, and Rest of the World) to provide in-depth information on the global scenario.

Global Bioinformatics Market, By Sector
Medical Biotechnology , Drug Development, Clinical Diagnostics, Molecular Medicine, Personalized Medicine, Preventive Medicine, Gene Therapy, Reproductive Biotechnology, Academics, Animal Biotechnology, Agriculture Biotechnology, Crop yield Improvement, Pests resistance, Improvement of plant resistance against abiotic stresses, Nutritional Quality Improvement, Others, Environmental Biotechnology, Waste Clean-Up, Alternative Energy Sources, Climate Change Studies, Forensic Biotechnology, Others

Global Bioinformatics Market, By Products & Services
Bioinformatics Knowledge Management Tools, Generalized Tools, Specialized Tools, Bioinformatics Platforms, Sequence Analysis Platforms, Sequence Alignment Platforms, Sequence Manipulation Platforms, Structural & Functional Analysis Platforms, Others, Bioinformatics Services, Sequencing Services, Database & Management, Data Analysis, Others

Global Bioinformatics Market, By Application
Genomics, Chemoinformatics & Drug Design, Proteomics, Transcriptomics, Metabolomics, Molecular phylogenetics, Others

Bioinformatics Market, By Geography
North America, Europe, Asia-Pacific, Rest of the World

Table of Content

3 Market Overview

3.1 Introduction
3.2 Evolution
3.3 Market Segmentation
3.3.1 Bioinformatics Market, By Sectors
3.3.2 Bioinformatics Market, By Product & Services
3.3.3 Bioinformatics Market, By Applications
3.4 Market Dynamics
3.4.1 Drivers Decreasing Cost Of DNA Sequencing Increasing Funding From Government And Private Organizations Rise In Initiatives By Research Institutes Growing Information Technology (IT) Support Fostering Nucleotide Sequences Submissions In EMBL, GenBank And DDBJ Technological Advancements Growing Applications Of Bioinformatics In The Drug Discovery And Development Process Bioinformatics Support Biomarker Discovery To Develop Safer Drugs Continuous Influx Of New Market Players Bioinformatics Support The Development Of Clinical Diagnostics And Personalized Medicine
3.4.2 Restraints Dearth Of Common Data Format For Integration Of Data Shortage Of Adequate Bioinformatics Professionals Dearth Of Well-Defined Standards Lack Of Interoperability Among Data Formats Pitfalls In Bioinformatics Patent Applications High Complexity Of Data Lack Of Adequate User-Friendly Tools
3.4.3 Opportunities Nanopore Sequencing Technology Cloud Technology Emerging Markets (India, China And Brazil)
3.4.4 Challenges Management Of High Volume Data Industry Consolidation
3.5 Market Share Analysis
3.5.1 Bioinformatics Market, By Sector
3.5.2 Bioinformatics Market, By Products & Services
3.5.3 Bioinformatics Market, By Application
3.5.4 Bioinformatics Market, By Geography

9 Company Profiles (Overview, Financials, Products & Services, Strategy, & Developments)

9.1 Accelrys, Inc.
9.2 Active Motif, Inc.
9.3 Affymetrix, Inc.
9.4 Agilent Technologies, Inc.
9.5 Biomatters, Ltd.
9.6 Biomax Informatics Ag
9.7 Clc Bio
9.8 Ocimum Biosolutions, Ltd.
9.9 Geneva Bioinfromatics (Genebio) Sa
9.10 Id Business Solutions Ltd.
9.11 Illumina, Inc.
9.12 Instem Plc
9.13 Integromics S.L.
9.14 Kinexus Bioinformatics Corporation
9.15 Knome, Inc.
9.16 Life Technologies Corporation
9.17 Nonlinear Dynamics Ltd.
9.18 Partek, Incorporated
9.19 Perkinelmer, Inc.
9.20 Textco Biosoftware, Inc.

For more details contact Mr. Priyank Tiwari: / +18883915441

No comments:

Post a Comment

Note: only a member of this blog may post a comment.